NCT06036238 The Outreach and Prevention at ALcohol Venues in East Africa Study (OPAL-East Africa- Aim 2) (OPAL-Aim 2)
| NCT ID | NCT06036238 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, San Francisco |
| Condition | HIV/AIDS |
| Study Type | INTERVENTIONAL |
| Enrollment | 400 participants |
| Start Date | 2024-05-17 |
| Primary Completion | 2026-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 400 participants in total. It began in 2024-05-17 with a primary completion date of 2026-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will evaluate the effect of a brief alcohol counseling intervention on PrEP and PEP adherence among adults with heavy alcohol use at high risk for HIV, while gaining insights into the facilitators, barriers, and cost-effectiveness of this approach.
Eligibility Criteria
Inclusion Criteria: * Adult (≥18 years) * HIV-uninfected (by rapid HIV antibody test) * AUDIT-C score of \>=4 for men and \>=3 for women * Attending a clinical visit for initiation of biomedical HIV prevention with oral or injectable PrEP or oral PEP (or the dapivirine vaginal ring, if available) * Has access to a mobile phone Exclusion Criteria: * Ineligible for PrEP based on MoH guidelines * Intention to move away from the study community in the coming year * Gross inebriation or inability to provide informed consent
Contact & Investigator
Gabriel Chamie, MD, MPH
PRINCIPAL INVESTIGATOR
University of California, San Francisco
Frequently Asked Questions
Who can join the NCT06036238 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying HIV/AIDS. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06036238 currently recruiting?
Yes, NCT06036238 is actively recruiting participants. Contact the research team at kara.marson@ucsf.edu for enrollment information.
Where is the NCT06036238 trial being conducted?
This trial is being conducted at Mbita, Kenya, Mbarara, Uganda.
Who is sponsoring the NCT06036238 clinical trial?
NCT06036238 is sponsored by University of California, San Francisco. The principal investigator is Gabriel Chamie, MD, MPH at University of California, San Francisco. The trial plans to enroll 400 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.